Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is the rate-limiting enzyme in cholesterol biosynthesis pathway that has been associated with cancer development. Although the connection between HMGCR and HER2 has been established, the function of HMGCR in the advanced progression of HER2 pos...
محفوظ في:
المؤلف الرئيسي: | Drahman, Rosmaizan |
---|---|
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2022
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://eprints.usm.my/57613/1/ROSMAIZAN%20BINTI%20DRAHMAN-FINAL%20THESIS%20P-UM000418%28R%29-24%20pages.pdf |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
بواسطة: Ali, Nursyazana Aqilah
منشور في: (2021) -
Investigating the effect of andrographolide on HMGCR protein expression in MDA-MB-231
بواسطة: Abdulateef, Al-Hakam Ahmed
منشور في: (2019) -
BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
بواسطة: Ahmad Zubir, Nurul Mahirah
منشور في: (2017) -
Transcriptomic profiling and validation of early onset estrogen receptor-positive breast cancer patients
بواسطة: Siddig, Alaa Abdelaziz Mahmoud
منشور في: (2023) -
Evaluation of fatty liver in breast cancer patients and its metastatic potential
بواسطة: Ahmad, Nor Hayati
منشور في: (2021)